The mechanisms of minocycline in alleviating ischemic stroke damage and cerebral ischemia-reperfusion injury.

[1]  Limeng Zhang,et al.  The Role of Nrf2 in Relieving Cerebral Ischemia-Reperfusion Injury , 2022, Current neuropharmacology.

[2]  He-yong Tang,et al.  Emerging Treatment Strategies for Cerebral Ischemia–Reperfusion Injury , 2022, Neuroscience.

[3]  M. Lou,et al.  Natural Products for the Treatment of Post-stroke Depression , 2022, Frontiers in Pharmacology.

[4]  X. Xiong,et al.  Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cerebral Ischemia/Reperfusion Injury , 2022, Frontiers in Cellular Neuroscience.

[5]  Simeng Gu,et al.  The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression , 2022, Frontiers in Psychiatry.

[6]  Ling He,et al.  Naoluo Xintong Decoction Ameliorates Cerebral Ischemia-Reperfusion Injury by Promoting Angiogenesis through Activating the HIF-1α/VEGF Signaling Pathway in Rats , 2022, Evidence-based complementary and alternative medicine : eCAM.

[7]  B. Law,et al.  Targeting Nrf2-Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals , 2022, Oxidative medicine and cellular longevity.

[8]  O. Seternes,et al.  Crosstalk between p38 MAPK and GR Signaling , 2022, International journal of molecular sciences.

[9]  B. Zhao,et al.  microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury , 2022, Neural regeneration research.

[10]  Jae Yeol Lee,et al.  Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke , 2022, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.

[11]  A. Simion,et al.  Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies , 2021, International journal of molecular sciences.

[12]  Yun Wei,et al.  Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review) , 2021, International journal of molecular medicine.

[13]  R. Turner,et al.  Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke? , 2021, International journal of molecular sciences.

[14]  Aishika Datta,et al.  Response to Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy , 2021, Translational Stroke Research.

[15]  Ł. Przykaza.  Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade , 2021, Frontiers in Immunology.

[16]  Yumei Zhang,et al.  Gamma-glutamyl transferase levels are associated with the occurrence of post-stroke cognitive impairment: a multicenter cohort study , 2021, BMC Neurology.

[17]  Yi-fan Zhou,et al.  Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy? , 2021, Frontiers in Immunology.

[18]  Heran Wang,et al.  Tuina plus acupuncture for post-stroke depression , 2021, Medicine.

[19]  Mei Yuan,et al.  Effectiveness and mechanisms of enriched environment in post-stroke cognitive impairment , 2021, Behavioural Brain Research.

[20]  P. Lei,et al.  Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications , 2021, Medicinal research reviews.

[21]  F. Chen,et al.  Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications , 2021, Oxidative medicine and cellular longevity.

[22]  Ruoli Chen,et al.  Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke , 2021, International journal of molecular sciences.

[23]  Mingming Zhou,et al.  Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways. , 2021, Biochemical pharmacology.

[24]  Yan-Ling Yuan,et al.  Anti-cerebral ischemia reperfusion injury of polysaccharides: A review of the mechanisms. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Xiuying Liu,et al.  Modulation of vascular integrity and neuroinflammation by peroxiredoxin 4 following cerebral ischemia-reperfusion injury. , 2021, Microvascular research.

[26]  Jie Kang,et al.  The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury , 2020, Frontiers in Neurology.

[27]  Chaoliang Tang,et al.  Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGFβ/ALK1/Smad1/5 signaling pathway , 2020, Aging.

[28]  Surojit Paul,et al.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies , 2020, Experimental Neurology.

[29]  T. Duong,et al.  Longitudinal multiparametric MRI study of hydrogen-enriched water with minocycline combination therapy in experimental ischemic stroke in rats , 2020, Brain Research.

[30]  Lihua Wang,et al.  Minocycline inhibits mTOR signaling activation and alleviates behavioral deficits in the Wistar rats with acute ischemia stroke. , 2020, CNS & neurological disorders drug targets.

[31]  Yi Yang,et al.  Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke , 2020, Current neuropharmacology.

[32]  K. Yan,et al.  Enriched environment improves post-stroke cognitive impairment and inhibits neuroinflammation and oxidative stress by activating Nrf2-ARE pathway , 2020, The International journal of neuroscience.

[33]  E. Kavanagh,et al.  Microglia: Agents of the CNS Pro-Inflammatory Response , 2020, Cells.

[34]  Hansen Chen,et al.  Targeting Myeloperoxidase (MPO) Mediated Oxidative Stress and Inflammation for Reducing Brain Ischemia Injury: Potential Application of Natural Compounds , 2020, Frontiers in Physiology.

[35]  M. Anderova,et al.  Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells , 2020, Frontiers in Cellular Neuroscience.

[36]  A. Suksamrarn,et al.  Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats , 2020, Pharmacological Reports.

[37]  M. Rachid,et al.  Minocycline treatment prevents depression and anxiety-like behaviors and promotes neuroprotection after experimental ischemic stroke , 2019, Brain Research Bulletin.

[38]  Amirhosein Sahebkar,et al.  Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review , 2019, Neural regeneration research.

[39]  Yanbo Zhang,et al.  Minocycline Ameliorates Depressive-Like Behavior and Demyelination Induced by Transient Global Cerebral Ischemia by Inhibiting Microglial Activation , 2019, Front. Pharmacol..

[40]  Y. Humeau,et al.  The next generation of approaches to investigate the link between synaptic plasticity and learning , 2019, Nature Neuroscience.

[41]  G. Rosenberg,et al.  Neuroinflammation: friend and foe for ischemic stroke , 2019, Journal of Neuroinflammation.

[42]  Zhitao Feng,et al.  Autophagy: novel insights into therapeutic target of electroacupuncture against cerebral ischemia/ reperfusion injury , 2019, Neural regeneration research.

[43]  S. Doré,et al.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. , 2019, American journal of physiology. Cell physiology.

[44]  N. Sims,et al.  Early treatment with minocycline following stroke in rats improves functional recovery and differentially modifies responses of peri-infarct microglia and astrocytes , 2019, Journal of Neuroinflammation.

[45]  Bailiu Ya,et al.  Uric Acid Protects against Focal Cerebral Ischemia/Reperfusion-Induced Oxidative Stress via Activating Nrf2 and Regulating Neurotrophic Factor Expression , 2018, Oxidative medicine and cellular longevity.

[46]  S. Jeun,et al.  Combination therapy of human bone marrow–derived mesenchymal stem cells and minocycline improves neuronal function in a rat middle cerebral artery occlusion model , 2018, Stem Cell Research & Therapy.

[47]  A. Kulesh,et al.  Cytokine Response, Tract-Specific Fractional Anisotropy, and Brain Morphometry in Post-Stroke Cognitive Impairment. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[48]  Ye Hua,et al.  Minocycline Promotes BDNF Expression of N2a Cells via Inhibition of miR-155-Mediated Repression After Oxygen-Glucose Deprivation and Reoxygenation , 2018, Cellular and Molecular Neurobiology.

[49]  M. Hamblin,et al.  Neural stem cell therapy for subacute and chronic ischemic stroke , 2018, Stem Cell Research & Therapy.

[50]  Z. Cai,et al.  An Antioxidant Role by Minocycline Via Enhancing the Activation of LKB1/AMPK Signaling in the Process of Cerebral Ischemia Injury. , 2018, Current molecular medicine.

[51]  M. Yenari,et al.  Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke , 2017, Front. Neurol..

[52]  Fen-Lei F Chang,et al.  A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury , 2017, Translational Stroke Research.

[53]  Y. Naderi,et al.  Neuroprotective effect of minocycline on cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory and anti-oxidant properties in male rat , 2017, Brain Research Bulletin.

[54]  Jie Fu,et al.  [Minocycline Prevent Microglial Activation via Suppression of Adenosine A 2A Receptor in a Rat Stroke Ischemia/Reperfusion Model]. , 2017, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[55]  K. Suk,et al.  Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders. , 2016, Biochemical pharmacology.

[56]  G. Fink,et al.  Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells , 2016, Journal of neuroscience research.

[57]  N. Nagai,et al.  A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia , 2016, Front. Cell. Neurosci..

[58]  Wenbin Dong,et al.  Minocycline induces protective autophagy in vascular endothelial cells exposed to an in vitro model of ischemia/reperfusion-induced injury , 2015, Biomedical reports.

[59]  H. Ding,et al.  Autophagy in cerebral ischemia and the effects of traditional Chinese medicine. , 2015, Journal of integrative medicine.

[60]  Xiaog-gang Li,et al.  [Effects of Minocycline on the Neuronal Plasticity in Rats after Focal Cerebral Ischemia Reperfusion Injury]. , 2015, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[61]  X. Xiong,et al.  Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats , 2015, Metabolic Brain Disease.

[62]  D. Sieroń,et al.  Endovascular treatment of acute ischemic stroke - own experience. , 2015, Neurologia i neurochirurgia polska.

[63]  Jian Liang,et al.  MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo , 2015, Journal of Neuroinflammation.

[64]  M. Xiao,et al.  Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the hippocampus of cerebral ischemia rats and improves behavioral deficits , 2015, Neuropsychiatric disease and treatment.

[65]  Jeffrey F. Thompson,et al.  Attenuation of acute stroke injury in rat brain by minocycline promotes blood–brain barrier remodeling and alternative microglia/macrophage activation during recovery , 2015, Journal of Neuroinflammation.

[66]  S. Nazarbaghi,et al.  An open‐label evaluator‐blinded clinical study of minocycline neuroprotection in ischemic stroke: gender‐dependent effect , 2015, Acta neurologica Scandinavica.

[67]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[68]  D. Hess,et al.  A 2 × 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model , 2014, Experimental & Translational Stroke Medicine.

[69]  P. Codogno,et al.  Regulation of autophagy by amino acids and MTOR-dependent signal transduction , 2014, Amino Acids.

[70]  M. Aras,et al.  Protective Effects of Minocycline against Short-Term Ischemia-Reperfusion Injury in Rat Brain , 2014, Pediatric Neurosurgery.

[71]  F. Sharp,et al.  Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  C. Power,et al.  Inflammasomes in the CNS , 2014, Nature Reviews Neuroscience.

[73]  G. Hankey,et al.  Intravenous Minocycline in Acute Stroke: A Randomized, Controlled Pilot Study and Meta-analysis , 2013, Stroke.

[74]  Ming-Rong Zhang,et al.  Monitoring Neuroprotective Effects Using Positron Emission Tomography With [11C]ITMM, a Radiotracer for Metabotropic Glutamate 1 Receptor , 2013, Stroke.

[75]  R. Pi,et al.  Minocycline reduces oxygen–glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin β1 and phosphorylated Akt modulation , 2013, Neurological Sciences.

[76]  Jinbao Yin,et al.  Effect of minocycline on cerebral ischemia-reperfusion injury , 2013, Neural regeneration research.

[77]  Xinyue Qin,et al.  Minocycline promotes axonal regeneration through suppression of RGMa in rat MCAO/reperfusion model , 2013, Synapse.

[78]  T. Delibaşı,et al.  Treatment Efficacy with Bone Marrow Derived Mesenchymal Stem Cells and Minocycline in Rats After Cerebral Ischemic Injury , 2013, Stem Cell Reviews and Reports.

[79]  Jie Liu,et al.  Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia , 2013, Experimental Neurology.

[80]  Dai Zhang,et al.  Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice , 2012, Journal of neurochemistry.

[81]  M. Hoehn,et al.  Effects of minocycline on endogenous neural stem cells after experimental stroke , 2012, Neuroscience.

[82]  J. Switzer,et al.  Minocycline Prevents IL-6 Increase after Acute Ischemic Stroke , 2012, Translational Stroke Research.

[83]  P. Narasimhan,et al.  Minocycline-Preconditioned Neural Stem Cells Enhance Neuroprotection after Ischemic Stroke in Rats , 2012, The Journal of Neuroscience.

[84]  O. Witte,et al.  Effects of rehabilitative training and anti-inflammatory treatment on functional recovery and cellular reorganization following stroke , 2012, Experimental Neurology.

[85]  L. Bhatt,et al.  Potentiation of aspirin-induced cerebroprotection by minocycline: A therapeutic approach to attenuate exacerbation of transient focal cerebral ischaemia , 2012, Diabetes & vascular disease research.

[86]  J. Switzer,et al.  Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke , 2011, Stroke.

[87]  R. Knight,et al.  The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications. , 2011, Recent patents on cardiovascular drug discovery.

[88]  D. Hess,et al.  Minocycline Development for Acute Ischemic Stroke , 2011, Translational Stroke Research.

[89]  S. Susin,et al.  AIF‐mediated caspase‐independent necroptosis: A new chance for targeted therapeutics , 2011, IUBMB life.

[90]  Cheol Hong Park,et al.  Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. , 2011, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[91]  K. Tracey,et al.  Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia , 2010, The Journal of Immunology.

[92]  J. Switzer,et al.  Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study , 2010, Stroke.

[93]  Dong-Sun Han,et al.  Role of Rac1 GTPase in NADPH Oxidase Activation and Cognitive Impairment Following Cerebral Ischemia in the Rat , 2010, PloS one.

[94]  C. Hsieh,et al.  Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABAB1 receptor expression in transient focal cerebral ischemia in rats , 2010, Acta Pharmacologica Sinica.

[95]  S. Fagan,et al.  Repurposing an Old Drug to Improve the Use and Safety of Tissue Plasminogen Activator for Acute Ischemic Stroke: Minocycline , 2010, Pharmacotherapy.

[96]  D. Hess,et al.  Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke , 2009, BMC Neuroscience.

[97]  Susan C Fagan,et al.  Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential , 2009, Stroke.

[98]  M. Shigemori,et al.  Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. , 2009, Biochemical and biophysical research communications.

[99]  Xiaohong Xu,et al.  Environmental Enrichment Induces Synaptic Structural Modification After Transient Focal Cerebral Ischemia in Rats , 2009, Experimental biology and medicine.

[100]  L. McCullough,et al.  Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[101]  K. Rhodes,et al.  Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke , 2008, Stroke.

[102]  M. Hazekawa,et al.  Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1–Inhibiting Mechanism , 2008, Stroke.

[103]  S. L. Mehta,et al.  Molecular Mechanisms of Apoptosis in Cerebral Ischemia: Multiple Neuroprotective Opportunities , 2008, Molecular Neurobiology.

[104]  S. Heiland,et al.  Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat—Effects on BBB breakdown and MMP expression in the acute and subacute phase , 2008, Brain Research.

[105]  M. Boaz,et al.  Minocycline treatment in acute stroke , 2007, Neurology.

[106]  Yu Zhou,et al.  Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats , 2007, Acta Pharmacologica Sinica.

[107]  G. Rosenberg,et al.  Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. , 2007, Neurosurgical focus.

[108]  Y. Weng,et al.  Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia , 2007, Experimental Neurology.

[109]  L. Toledo-Pereyra,et al.  Akt in Ischemia and Reperfusion , 2007, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[110]  P. Weinstein,et al.  Chronic Treatment With Minocycline Preserves Adult New Neurons and Reduces Functional Impairment After Focal Cerebral Ischemia , 2007, Stroke.

[111]  T. Dawson,et al.  Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death , 2006, Proceedings of the National Academy of Sciences.

[112]  D. Hess,et al.  Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke , 2006, BMC Neuroscience.

[113]  Rona G. Giffard,et al.  Microglia Potentiate Damage to Blood–Brain Barrier Constituents: Improvement by Minocycline In Vivo and In Vitro , 2006, Stroke.

[114]  T. Yamashima,et al.  Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage , 2005, Brain Research.

[115]  G. Giaccone,et al.  Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.

[116]  K. Suk.  Minocycline suppresses hypoxic activation of rodent microglia in culture , 2004, Neuroscience Letters.

[117]  John H. Zhang,et al.  Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. , 2004, Frontiers in bioscience : a journal and virtual library.

[118]  D. Hess,et al.  Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats , 2004, BMC neurology.

[119]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[120]  O. Lindvall,et al.  Inflammation is detrimental for neurogenesis in adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[121]  T. Sugawara,et al.  Overexpression of Copper/Zinc Superoxide Dismutase in Transgenic Rats Protects Vulnerable Neurons against Ischemic Damage by Blocking the Mitochondrial Pathway of Caspase Activation , 2002, The Journal of Neuroscience.

[122]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[123]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[124]  W. X,et al.  Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies. , 2016, Biochemistry & pharmacology : open access.

[125]  K. Prasad,et al.  Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial. , 2012, Neurology India.

[126]  X. Jian.  Effect of minocycline on neuronal apoptosis after cerebral ischemia-reperfusion rats , 2012 .

[127]  Zhao Lian-don.  The Effect of Minocycline on Infarct Volume and Glutamic Acid Levels in Acute Cerebral Ischemia-Reperfusion in Rats , 2012 .

[128]  Lu Bing-xu.  Effects of minocycline on brain inflammation of rat focal cerebral ischemia-reperfusion injury , 2011 .

[129]  J. Rafols,et al.  The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. , 2011, Journal of neurosurgery.

[130]  W. Guan,et al.  Drug repurposing for vascular protection after acute ischemic stroke. , 2011, Acta neurochirurgica. Supplement.

[131]  Lu Bing-xun.  Influence of minocycline on expression of CD11b and caspase-3 in rat brain after focal cerebral ischemia-reperfusion , 2010 .

[132]  Wang Xue-jun.  Effects of Minocycline on Activity and Expression of Caspase-3 Induced by Focal Cerebral Ischemia Following Reperfusion , 2009 .

[133]  Zhao Li-bo.  Effects of Minocycline on Study and Memory Dysfunction and Energy Metabolism in Reperfusion Injury after Focal Cerebral Ischemia , 2009 .

[134]  Sun Sheng-gan.  Effects of minocycline on the activity of gelatinases and the blood-brain barrier following transient focal cerebral ischemia , 2007 .